Vertex Reports Second-Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Vertex Pharma (VRTX) Tops Q2 EPS by 54c, Revenues Beat; Raises FY20 Revenue Guidance
July 30, 2020 4:03 PM EDTVertex Pharma (NASDAQ: VRTX) reported Q2 EPS of $2.61, $0.54 better than the analyst estimate of $2.07. Revenue for the quarter came in at $1.52 billion versus the consensus estimate of $1.39 billion.
"This has been an exceptional first half for Vertex on all fronts and most importantly, in our efforts to... More
